Hologic [HOLX] vs West Pharmaceutical [WST] Detailed Stock Comparison

Hologic Inc.

NASDAQ
Loading...

West Pharmaceutical Services Inc.

NYSE
Loading...

TLDR: Quick Comparison Summary

Based on 21 vital metrics comparison: Hologic Inc. wins in 11 metrics, West Pharmaceutical Services Inc. wins in 9 metrics, with 0 ties. Hologic Inc. appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Hologic Inc. West Pharmaceutical Services Inc. Better
P/E Ratio (TTM) 31.54 40.99 Hologic Inc.
Price-to-Book Ratio 3.23 6.94 Hologic Inc.
Debt-to-Equity Ratio 48.05 10.73 West Pharmaceutical Services Inc.
PEG Ratio -3.92 0.74 West Pharmaceutical Services Inc.
EV/EBITDA 12.68 24.63 Hologic Inc.
Profit Margin (TTM) 13.18% 16.85% West Pharmaceutical Services Inc.
Operating Margin (TTM) 22.99% 21.70% Hologic Inc.
EBITDA Margin (TTM) 22.99% 21.70% Hologic Inc.
Return on Equity 10.86% 19.13% West Pharmaceutical Services Inc.
Return on Assets (TTM) 7.43% 11.21% West Pharmaceutical Services Inc.
Free Cash Flow (TTM) $904.70M $468.90M Hologic Inc.
Dividend Yield N/A 0.46% N/A
1-Year Return 31.39% 48.18% West Pharmaceutical Services Inc.
Price-to-Sales Ratio (TTM) 4.11 6.72 Hologic Inc.
Enterprise Value $17.12B $21.43B West Pharmaceutical Services Inc.
EV/Revenue Ratio 4.15 6.65 Hologic Inc.
Gross Profit Margin (TTM) 55.96% 35.08% Hologic Inc.
Revenue per Share (TTM) $18 $45 West Pharmaceutical Services Inc.
Earnings per Share (Diluted) $2.41 $7.47 West Pharmaceutical Services Inc.
Beta (Stock Volatility) 0.70 1.15 Hologic Inc.
Short % of Float 3.66% 4.38% Hologic Inc.

Hologic Inc. vs West Pharmaceutical Services Inc. Stock Performance Analysis

Loading Price Chart...

HOLX
WST

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Hologic Inc.0.00%0.56%0.56%1.40%12.23%1.94%
West Pharmaceutical Services Inc.0.79%3.65%9.42%37.92%21.91%19.91%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Hologic Inc.31.39%-9.66%-0.85%110.15%246.29%206.74%
West Pharmaceutical Services Inc.48.18%-9.18%-6.66%345.01%1,441.58%1,794.12%

Performance & Financial Health Analysis: Hologic Inc. vs West Pharmaceutical Services Inc.

MetricHOLXWST
Market Information
Market Cap i$16.97B$22.07B
Market Cap CategoryLarge capLarge cap
10 Day Avg. Volume i12,273,0851,085,830
90 Day Avg. Volume i6,282,625930,327
Last Close$76.01$331.43
52 Week Range$51.90 - $76.07$206.80 - $336.82
% from 52W High-0.08%-1.60%
All-Time High$87.88 (May 01, 2023)$475.35 (Sep 06, 2021)
% from All-Time High-13.51%-30.28%
Growth Metrics
Quarterly Revenue Growth0.03%0.21%
Quarterly Earnings Growth-0.11%0.55%
Financial Health
Profit Margin (TTM) i0.13%0.17%
Operating Margin (TTM) i0.23%0.22%
Return on Equity (TTM) i0.11%0.19%
Debt to Equity (MRQ) i48.0510.73
Cash & Liquidity
Book Value per Share (MRQ)$23.51$44.11
Cash per Share (MRQ)$10.60$7.38
Operating Cash Flow (TTM) i$1.10B$715.30M
Levered Free Cash Flow (TTM) i$848.61M$275.66M
Dividends
Last 12-Month Dividend Yield iN/A0.46%
Last 12-Month Dividend iN/A$1.07

Valuation & Enterprise Metrics Analysis: Hologic Inc. vs West Pharmaceutical Services Inc.

MetricHOLX (Apr 19, 2026)WST (Apr 26, 2026)
Price Ratios
P/E Ratio (TTM) i31.5440.99
Forward P/E i15.6432.05
PEG Ratio i-3.920.74
Price to Sales (TTM) i4.116.72
Price to Book (MRQ) i3.236.94
Market Capitalization
Market Capitalization i$16.97B$22.07B
Enterprise Value i$17.12B$21.43B
Enterprise Value Metrics
Enterprise to Revenue i4.156.65
Enterprise to EBITDA i12.6824.63
Risk & Other Metrics
Beta i0.701.15
Book Value per Share (MRQ) i$23.51$44.11

Financial Statements Comparison: Hologic Inc. vs West Pharmaceutical Services Inc.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricHOLX (2025)WST (2025)
Revenue/Sales i4.10B3.07B
Cost of Goods Sold i1.98B1.97B
COGS % of Revenue i48.4%64.1%
Gross Profit i2.12B1.10B
Gross Margin i51.6%35.9%
Research & Development i248.20M74.30M
Operating Income (EBIT) i785.40M636.10M
Operating Margin i19.2%20.7%
EBITDA i1.17B822.70M
EBITDA Margin i28.5%26.8%
Pre-Tax Income i681.20M600.90M
Pre-Tax Income % of Revenue i16.6%19.5%
Income Tax i115.50M121.60M
Income Tax % of Revenue i2.8%4.0%
Net Income (Profit) i565.70M493.70M
Profit Margin i13.8%16.1%

Balance Sheet & Liquidity Metrics

MetricHOLX (2025)WST (2025)
Cash & Equivalents i1.96B791.30M
Total Current Assets i3.67B1.98B
Total Current Assets % of Revenue i89.5%64.4%
Total Current Liabilities i977.20M654.90M
Total Current Liabilities % of Revenue i23.8%21.3%
Long-Term Debt i2.59B298.40M
Long-Term Debt % of Revenue i63.2%9.7%
Total Shareholders Equity i5.05B3.18B
Retained Earnings i3.41B4.37B
Retained Earnings % of Revenue i83.2%142.3%
Property, Plant & Equipment i1.07B296.40M

Cash Flow Statement Comparison

MetricHOLX (2025)WST (2025)
Operating Cash Flow i831.50M753.00M
Operating Cash Flow % of Revenue i20.3%24.5%
Capital Expenditures i-78.20MN/A
Free Cash Flow i904.70M468.90M
FCF Margin i22.1%15.3%
Debt Repayment i-1.20B-1.10M
Common Stock Repurchase i-752.90M-136.80M

Short Interest & Institutional Ownership Analysis

MetricHOLXWST
Shares Short i7.10M2.66M
Short Ratio i2.783.18
Short % of Float i3.66%4.38%
Shares Outstanding i223.07M70.90M
Float Shares i221.21M70.15M
% Held by Insiders i0.84%0.64%
% Held by Institutions i96.52%99.21%
% Held by Public i2.64%0.15%

Dividend Analysis & Yield Comparison: Hologic Inc. vs West Pharmaceutical Services Inc.

MetricHOLXWST
Last 12-Month Dividend iN/A$1.07
Last 12-Month Dividend Yield iN/A0.46%
3-Year Avg Annual Dividend iN/A$0.82
3-Year Avg Dividend Yield iN/A0.07%
3-Year Total Dividends iN/A$2.46
Ex-Dividend DateN/AJan 28, 2026